SBRT-LATTICE-PATHY
Impact of Partial Stereotactic Body Radiotherapy in Hypoxic Segments of Large-volume Unresectable Tumors (SBRT-LATTICE-PATHY) - a Prospective Phase II Study.
University of Sao Paulo General Hospital
20 participants
Apr 28, 2026
INTERVENTIONAL
Conditions
Summary
To assess the importance of using SBRT-LATTICE-PATHY for the radiotherapy treatment of large tumors that would be considered intractable by currently used standard techniques. In this present study, the investigators will have the possibility of combining SBRT and LATTICE techniques, incorporating the concept of hypoxic tissue irradiation, which are potential modulators of abscopal and bystander effects, performing partial punctual treatment in the vertex region, without the need for irradiation of the entire tissue volume, further improving safety in relation to possible toxicities.
Eligibility
Inclusion Criteria7
- age =or> 18 years;
- Eastern Cooperative Oncology Group (ECOG) performance status < 2; benign and malignant tumors for which the use of radiotherapy is well established in the literature;
- tumors =or> 340 cm³ or with a largest diameter =or> 7 cm;
- no indication for any other type of treatment due to lack of proven clinical benefit (surgery, chemotherapy, standard radiotherapy, immunotherapy, targeted therapy, etc.);
- Palliative Prognostic Index (PPI) =or< 2;
- metastatic disease in the central nervous system (CNS), if present, controlled (up to 3 metastases, each up to 1 cm);
- up to 5 extracranial distant metastases (nodal or extranodal) =or< 5 cm; signed Informed Consent Form (ICF).
Exclusion Criteria7
- cases in which tumor volume and/or the patient's clinical condition make adequate immobilization/simulation impossible;
- previous local radiotherapy;
- pregnant patients;
- autoimmune diseases;
- genetic instability syndromes;
- ongoing systemic therapy;
- renal insufficiency that prevents the use of iodinated contrast.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
SBRT-LATTICE-PATHY, a single dose of 24Gy in intratumoral vertices located in hypoxic regions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07645261